Skip to content

Exagen Inc.

XGN

CIK 0001274737

← back to feed
Revenue (TTM)
$67.25M
+19.7% YoY Q1 May 2026
Net Income (TTM)
−$19.25M
−32.0% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.89
−12.0% YoY Q1 May 2026
Gross Margin
59.2%
Q1 May 2026
Operating Margin
-18.6%
Q1 May 2026
Net Margin
-28.6%
Q1 May 2026
Free Cash Flow (TTM)
−$40.7M
Q1 May 2026
Cash
$21.51M
Q1 May 2026
Total Debt
$22.87M
Q1 May 2026
Shares Outstanding
24.16M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings